Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.

Name: Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.
Creator: Sara Cherry
Published: 2021-03-16T10:35:51.450Z
Keywords: High-Throughput Screening, Drug Screening

Cherry, Sara

doi:10.17632/4m9sygn632.2

Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.

Published: 16-03-2021| Version 2 | DOI: 10.17632/4m9sygn632.2

Contributor:

Sara Cherry

Description

Supplementary Data sets

Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.

Description

Files

Related Links